Tech Investors

Redmile Group

Redmile Group is an investing group that backs tech companies raising capital.

Venture Investor Overview

Venture Investor
Redmile Group
Status
Active
Investor Type
Other
Activity Level
99 transactions
Funds Raised
At least $842 million
Industry Focus
Biopharmaceutical

Contact Information

Contact
Jeremy Green
Title
Partner
Mailing Address
1 Letterman Dr. Building D The Presidio of San Francisco D3-300
San Francisco, CA 94129
USA
Phone
(415) 489-9980
Website
www.redmilegroup.com
Email Address
Not Recorded

Background Information

Overview
Redmile Group is a financial advisory firm.
Profile
Redmile Group LinkedIn Company Profile
Social Media
Redmile Group Company Twitter Account
Company News
Redmile Group News
Facebook
Redmile Group on Facebook
YouTube
Redmile Group on YouTube
Last Transaction
7/21/2024

Transaction History

Our records indicate that Redmile Group invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
Gro Biosciences
7/21/2024
$60,300,000
Attovia Therapeutics
5/9/2024
$105,000,000
Star Therapeutics
9/5/2023
$90,000,000
Abcuro
8/18/2023
$155,000,000
ADARx Pharmaceuticals
8/9/2023
$200,000,000
ElevateBio
5/24/2023
$401,000,000
Boundless Bio
5/16/2023
$100,000,000
Orbital Therapeutics
4/26/2023
$270,000,000
Neuron23
3/30/2022
$100,000,000
Gro Biosciences
11/6/2021
$25,000,000
Mammoth Biosciences
9/10/2021
$195,000,000
Attralus
9/9/2021
$116,000,000
Prime Medicine
7/14/2021
$200,000,000
Strand Therapeutics
6/24/2021
$52,000,000
RayzeBio
6/16/2021
$108,000,000
Ceribell
5/3/2021
$53,000,000
Boundless Bio
4/29/2021
$105,000,000
Adagio Therapeutics
4/20/2021
$336,000,000
Entrada Therapeutics
4/1/2021
$116,000,000
Amunix Pharmaceuticals
3/5/2021
$117,000,000
Verve Therapeutics
1/20/2021
$94,000,000
Impulse Dynamics
1/13/2021
$60,000,000
SomaLogic
12/23/2020
$81,000,000
Neurogene
12/17/2020
$115,000,000
Neuron23
12/17/2020
$113,500,000
RayzeBio
12/9/2020
$105,000,000
MedAvail
11/20/2020
$84,000,000
AbSci
10/21/2020
$65,000,000
Lava Therapeutics
9/18/2020
$83,000,000
Escient Pharmaceuticals
9/15/2020
$77,500,000
Science 37
8/21/2020
$40,000,000
Annexon Biosciences
7/3/2020
$100,000,000
Shattuck Labs
6/16/2020
$118,000,000
Clear Labs
5/18/2020
$180,000,000
CorVent Medical
5/12/2020
$4,500,000
LifeSprout
4/28/2020
$28,500,000
ElevateBio
3/31/2020
$170,000,000
Kymera Therapeutics
3/13/2020
$102,000,000
Nurix Therapeutics
3/13/2020
$120,000,000
Amunix Pharmaceuticals
3/5/2020
$73,000,000
Pliant Therapeutics
3/4/2020
$100,000,000
Sonendo
1/8/2020
$85,000,000
ArcherDX
12/19/2019
$55,000,000
Zentalis Pharmaceuticals
12/11/2019
$85,000,000
Nuvation Bio
10/30/2019
$275,000,000
Augmedix
10/25/2019
$19,000,000
Repare Therapeutics
9/5/2019
$82,500,000
IGM Biosciences
7/9/2019
$102,000,000
ElevateBio
5/14/2019
$150,000,000
Beam Therapeutics
3/7/2019
$135,000,000
HOOKIPA Pharma
2/27/2019
$37,400,000
Neurogene
2/13/2019
$68,500,000
Cabaletta Bio
1/4/2019
$50,000,000
Akero Therapeutics
12/13/2018
$70,000,000
Aprea Therapeutics
12/3/2018
$56,869,550
Stoke Therapeutics
10/24/2018
$90,000,000
Atreca
9/13/2018
$125,000,000
OncoResponse
9/12/2018
$40,000,000
MedAvail
7/26/2018
$16,600,000
Attenua
5/1/2018
$35,000,000
TCR2 Therapeutics
3/22/2018
$125,000,000
Scholar Rock
1/4/2018
$47,000,000
Allakos
12/14/2017
$100,000,000
Call9
9/15/2017
$24,000,000
Replimune
9/11/2017
$55,000,000
Deciphera Pharmaceuticals
6/2/2017
$52,000,000
Xeris Pharmaceuticals
5/20/2017
$30,000,000
Science 37
4/26/2017
$29,000,000
Virta Health
3/9/2017
$37,000,000
Augmedix
12/9/2016
$23,000,000
Genalyte
11/22/2016
$36,000,000
Science 37
10/19/2016
$31,000,000
True North Therapeutics
10/19/2016
$45,000,000
Augmedix
4/25/2016
$17,000,000
Yumanity
2/11/2016
$45,000,000
Syros Pharmaceuticals
1/13/2016
$40,000,000
Xeris Pharmaceuticals
1/12/2016
$41,000,000
First Aid Shot Therapy
11/18/2015
$24,000,000
Gritstone Oncology
10/21/2015
$102,000,000
Audentes Therapeutics
10/14/2015
$65,000,000
Genalyte
8/19/2015
$44,000,000
WaVe Life Sciences
8/18/2015
$66,000,000
Afferent Pharmaceuticals
7/8/2015
$55,000,000
CytomX Therapeutics
6/17/2015
$70,000,000
Jounce Therapeutics
4/23/2015
$56,000,000
Scioderm
12/19/2014
$20,000,000
Blueprint Medicines
11/14/2014
$50,000,000
MedAvail
10/18/2014
$30,000,000
Invitae
10/13/2014
$120,000,000
Bellicum Pharmaceuticals
8/27/2014
$55,000,000
Avalanche Biotech
4/23/2014
$55,000,000
One Medical Group
4/18/2014
$40,000,000
First Aid Shot Therapy
2/10/2014
Unknown
Invitae
12/12/2013
$40,000,000
Trivascular Technologies
11/18/2013
$40,000,000
Scanadu
11/13/2013
$10,500,000
Foundation Medicine
9/21/2012
$56,000,000
Trivascular Technologies
6/5/2012
$60,000,000
Castlight Health
5/1/2012
$100,000,000

 

Investor Contacts

Title
Name
Email & Social
Partner
Jeremy Green
  Jeremy Green LinkedIn Profile  Jeremy Green Twitter Account  Jeremy Green News  Jeremy Green on Facebook

 

Funds

Our database includes the following fund closing(s) for Redmile Group. If we are missing funds, please contact us.

Fund Description
Vintage Date
Fund Amount
Redmile Capital Offshore Fund
2/14/2018
$430,725,000
Redmile Private Investments II
12/30/2016
$110,597,517
Redmile Capital Fund
3/18/2011
$300,682,410

 

Portfolio Companies

Redmile Group has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
Abcuro
AbSci
Adagio Therapeutics
ADARx Pharmaceuticals
Afferent Pharmaceuticals
Akero Therapeutics
Allakos
Amunix Pharmaceuticals
Annexon Biosciences
Aprea Therapeutics
ArcherDX
Atreca
Attenua
Attovia Therapeutics
Attralus
Audentes Therapeutics
Augmedix
Avalanche Biotech
Beam Therapeutics
Bellicum Pharmaceuticals
Blueprint Medicines
Boundless Bio
Cabaletta Bio
Call9
Castlight Health
Ceribell
Clear Labs
CorVent Medical
CytomX Therapeutics
Deciphera Pharmaceuticals
ElevateBio
Entrada Therapeutics
Escient Pharmaceuticals
First Aid Shot Therapy
Foundation Medicine
Genalyte
Gritstone Oncology
Gro Biosciences
HOOKIPA Pharma
IGM Biosciences
Impulse Dynamics
Invitae
Jounce Therapeutics
Kymera Therapeutics
Lava Therapeutics
LifeSprout
Mammoth Biosciences
MedAvail
Neurogene
Neuron23
Nurix Therapeutics
Nuvation Bio
OncoResponse
One Medical Group
Orbital Therapeutics
Pliant Therapeutics
Prime Medicine
RayzeBio
Repare Therapeutics
Replimune
Scanadu
Scholar Rock
Science 37
Scioderm
Shattuck Labs
SomaLogic
Sonendo
Star Therapeutics
Stoke Therapeutics
Strand Therapeutics
Syros Pharmaceuticals
TCR2 Therapeutics
Trivascular Technologies
True North Therapeutics
Verve Therapeutics
Virta Health
WaVe Life Sciences
Xeris Pharmaceuticals
Yumanity
Zentalis Pharmaceuticals

 

 

 

 

Browse more tech investors:

Ray Carriers | Regal Funds Management

 

Share this article

 

About Our Tech Company Investor Database

The tech investor dataset above is provided by VentureDeal.com, a leading supplier of tech investor funding data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.